We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

75 hedge funds and large institutions have $273M invested in Collegium Pharmaceutical in 2017 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 28 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 17

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

4.74% more ownership

Funds ownership: 83.33% → 88.06% (+4.7%)

4% more funds holding

Funds holding: 72 → 75 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less capital invested

Capital invested by funds: $307M → $273M (-$33.9M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $506K

Holders
75
Holders Change
+3
Holders Change %
+4.17%
% of All Funds
1.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
28
Reduced
17
Closed
7
Calls
–
Puts
$506K
Net Calls
-$506K
Net Calls Change
-$126K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$9.08M
2
Citadel Advisors
Citadel Advisors
Florida
+$5.44M
3
Prudential Financial
Prudential Financial
New Jersey
+$2.37M
4
JGC
J. Goldman & Co
New York
+$2.33M
5
Macquarie Group
Macquarie Group
Australia
+$2.33M

Top Sellers

Rank Fund Capital Flow
1
PC
Pier Capital
Connecticut
-$4.95M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.75M
3
CCM
Cadian Capital Management
New York
-$2.18M
4
BCMNY
Buckingham Capital Management (New York)
New York
-$1.16M
5
SAM
Sectoral Asset Management
Quebec, Canada
-$654K
Name Holding Trade Value Shares
Change 		Change in
Stake
BGIM
26
Brandywine Global Investment Management
Pennsylvania
$1.23M +$1.29M +116,999 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$1.1M -$2.52K -229 -0.2%
Goldman Sachs
28
Goldman Sachs
New York
$841K +$352K +31,907 +66%
NC
29
NBW Capital
Massachusetts
$736K +$98.9K +8,972 +15%
Deutsche Bank
30
Deutsche Bank
Germany
$689K +$20.1K +1,825 +3%
TA
31
Teachers Advisors
New York
$627K +$2.25K +204 +0.3%
TCIM
32
TIAA CREF Investment Management
New York
$621K -$22.3K -2,025 -3%
RHJA
33
Rice Hall James & Associates
California
$592K +$623K +56,464 New
GIP
34
Granite Investment Partners
California
$547K -$301K -27,263 -34%
MCM
35
Moore Capital Management
New York
$525K -$276K -25,000 -33%
Wells Fargo
36
Wells Fargo
California
$475K +$56.6K +5,136 +13%
Charles Schwab
37
Charles Schwab
California
$473K – – –
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$375K -$49K -4,448 -11%
Swiss National Bank
39
Swiss National Bank
Switzerland
$318K – – –
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$298K -$7.83K -710 -2%
AllianceBernstein
41
AllianceBernstein
Tennessee
$290K – – –
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$290K +$2.54K +230 +0.8%
TA
43
Teton Advisors
New York
$283K +$298K +27,000 New
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$267K +$281K +25,463 New
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$254K – – –
Commonwealth Equity Services
46
Commonwealth Equity Services
Massachusetts
$218K -$992 -90 -0.4%
ARTA
47
A.R.T. Advisors
New York
$212K +$224K +20,294 New
DTL
48
Dynamic Technology Lab
Singapore
$201K +$212K +19,234 New
CS
49
Credit Suisse
Switzerland
$193K +$203K +18,432 New
JP Morgan Chase
50
JP Morgan Chase
New York
$192K +$203K +18,419 New
1
2
3 4

COLL Hedge Fund Activity: Q3 2017 in Review

75 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q3 2017, worth a combined $273M — down 11% from $307M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new COLL positions and 7 closed out — a net gain of 3 holders — while 28 added to existing stakes and 17 trimmed.

The largest buyer was Millennium Management, adding an estimated $9.08M. The largest seller was Pier Capital, exiting entirely with an estimated $4.95M sold.

  • 75 institutional investors held Collegium Pharmaceutical (COLL) as of Q3 2017, up from 72 in Q2 2017.
  • Funds reported $273M of Collegium Pharmaceutical stock for Q3 2017, down 11% quarter-over-quarter.
  • 10 funds opened new Collegium Pharmaceutical positions in Q3 2017 and 7 closed out, a net change of +3 holders.
  • The largest Collegium Pharmaceutical buyer in Q3 2017 was Millennium Management, an estimated $9.08M added.
  • The largest Collegium Pharmaceutical seller in Q3 2017 was Pier Capital, an estimated $4.95M sold.

Based on aggregated 13F filings for Q3 2017.